HCA Healthcare’s (HCA) “Buy” Rating Reiterated at Truist Financial

Truist Financial reiterated their buy rating on shares of HCA Healthcare (NYSE:HCA) in a research report report published on Tuesday morning,Benzinga reports. They currently have a $510.00 price objective on the stock, up from their previous price objective of $495.00.

Other equities analysts have also issued reports about the company. Wells Fargo & Company boosted their price target on HCA Healthcare from $381.00 to $468.00 and gave the stock an “equal weight” rating in a research report on Monday. Wall Street Zen raised shares of HCA Healthcare from a “hold” rating to a “buy” rating in a research report on Saturday, October 31st. Raymond James Financial set a $528.00 price objective on shares of HCA Healthcare in a research note on Tuesday, July 7th. Oppenheimer reduced their target price on shares of HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating on the stock in a research report on Monday, July 27th. Finally, Bank of America upped their target price on shares of HCA Healthcare from $450.00 to $500.00 and gave the company a “neutral” rating in a research note on Wednesday, October 28th. Sixteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $480.13.

HCA Healthcare Price Performance

NYSE:HCA opened at $508.74 on Tuesday. The business’s 50-day moving average is $442.16 and its two-hundred day moving average is $445.10. HCA Healthcare has a 12 month low of $353.99 and a 12 month high of $556.52. The firm has a market capitalization of $106.27 billion, a PE ratio of 17.04, a price-to-earnings-growth ratio of 1.71 and a beta of 1.11.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Tuesday, October 27th. The company reported $7.22 earnings per share for the quarter, topping the consensus estimate of $6.65 by $0.57. HCA Healthcare had a negative return on equity of 198.52% and a net margin of 8.61%. The company had revenue of $19.85 billion during the quarter, compared to the consensus estimate of $19.33 billion. During the same quarter in the prior year, the business earned $6.96 earnings per share. The company’s revenue was up 3.6% compared to the same quarter last year. Equities analysts anticipate that HCA Healthcare will post 30.15 EPS for the current year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 29th. Stockholders of record on Tuesday, December 15th will be given a dividend of $0.78 per share. The ex-dividend date of this dividend is Tuesday, December 15th. This represents a $3.12 annualized dividend and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.34%.

Institutional Trading of HCA Healthcare

Hedge funds and other institutional investors have recently bought and sold shares of the company. BlackRock Inc. bought a new position in HCA Healthcare during the second quarter valued at about $5,069,974,000. Wellington Management Group LLP raised its position in HCA Healthcare by 20.5% in the second quarter. Wellington Management Group LLP now owns 4,707,473 shares of the company’s stock worth $1,835,397,000 after acquiring an additional 799,761 shares in the last quarter. Darsana Capital Partners LP raised its position in HCA Healthcare by 46.7% in the second quarter. Darsana Capital Partners LP now owns 1,100,000 shares of the company’s stock worth $428,879,000 after acquiring an additional 350,000 shares in the last quarter. Legal & General Group Plc acquired a new stake in HCA Healthcare in the 2nd quarter valued at about $410,992,000. Finally, Jupiter Topco LLC bought a new position in shares of HCA Healthcare during the 2nd quarter valued at about $371,138,000. 62.73% of the stock is owned by institutional investors.

Trending Headlines about HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA completed a $6.5 billion senior notes offering, providing financing that may support its capital needs; the added debt also carries obligations. HCA Healthcare Completes $6.5 Billion Senior Notes Offering
• Positive Sentiment: A Democratic midterm sweep sparked gains across hospital stocks as investors anticipated a more favorable policy environment. However, the expected relief depends on legislative action and faces a December funding fight, so the potential benefit remains uncertain. Hospital Stocks Soared as Democrats Took Congress
• Positive Sentiment: HCA plans to have 10,000 physicians using ambient AI by year-end, a rollout that could support clinical workflows and efficiency. HCA Healthcare to have 10,000 physicians on ambient AI by year-end
• Positive Sentiment: Truist reaffirmed its Buy rating, while a separate report noted a bullish technical signal after HCA moved above its 20-day average. Truist Financial Reaffirms Buy Rating for HCA Healthcare
• Neutral Sentiment: HCA’s AI chief emphasized that delaying some rollouts can be the right decision, suggesting the company is taking a measured approach to adoption. HCA Healthcare AI chief on rollouts: ‘Not yet’ can be the right call
• Negative Sentiment: A report flags payer pressure as a concern in HCA’s 2027 outlook, which could weigh on expectations if reimbursement trends worsen. HCA Healthcare stock faces payer pressure in 2027 outlook

About HCA Healthcare

HCA Healthcare, Inc is a healthcare services company that operates hospitals, ambulatory surgery centers, emergency care facilities, physician practices and other healthcare sites. Its facilities provide a broad range of services, including acute and emergency care, surgery, cardiology, oncology, women’s and children’s services, behavioral health and outpatient care.

The company serves patients primarily across the United States through a network of healthcare facilities in numerous states.